See our technology explained. Gain insights from Benitec’s senior management and research teams.

CommSec 24 Nov 16: Benitec Biopharma (BLT) CEO, Greg West
Tom Piotrowski speaks with Benitec Biopharma (BLT) CEO, Greg West about the company’s gene silencing technology and its new deal with US medical company Nant.
Benitec’ CBO presents at ASX Spotlight Conference in New York
ASX Spotlight Series 2015
Benitec’s CBO on Sky Business News
See the video interview
RNA Interference, siRNA and ddRNAi
Benitec's ddRNAi explained
Benitec’s Investor, Technology, Clinical Trial and Health Sector Update
Get the full picture.
Recombinant DNA Advisory Committee
Watch full proceedings of July 11, 2013 meeting
Benitec and CCIA: Advancing Lung Cancer Care
Watch the Innovation Matters video
Benitec Acquires Tacere Hepatitis C Program
Watch the CEO interview
Gene Silencing for Hepatitis B & C
See the science explained
Transformational Therapeutics
Share our vision for Gene Silencing